Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Horcicka

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Vnitrni Lekarstvi|October 1, 1987
[The importance of collectivism training in medical schools]M Vykydal, V Horcicka, O Weinbergová, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1985
Platelet aggregation in primary hyperlipoproteinemiaH Vaverková, O Weinbergová, M Kubasta, et al.
Vnitrni Lekarstvi|September 1, 1986
[Familial combined hyperlipidemia. I. Variation in the lipoprotein picture]H Vaverková, O Weinbergová, V Horcicka, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1986
Familial combined hyperlipidemia. Part II. Clinical pictureH Vaverková, O Weinbergová, V Horcicka, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1986
Familial combined hyperlipidemia. Part I. Lipid values and the lipoprotein patternH Vaverková, O Weinbergová, V Horcicka, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1982
Biochemical analysis of articular environment in diseases of motor apparatusP Vrublovský, M Vykydal, E Pĕgrímová, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1987
Effect of genetic heterogeneity of hypertriglyceridemia upon the risk of coronary heart diseaseH Vaverková, O Weinbergová, V Horcicka, et al.
Vnitrni Lekarstvi|September 1, 1986
[Familial combined hyperlipidemia. II. Risk of ischemic heart disease]H Vaverková, O Weinbergová, V Horcicka, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1985
Type III hyperlipoproteinaemia: clinicopathological observation of five casesH Vaverková, J Dusek, M Kubasta, et al.
Vnitrni Lekarstvi|May 1, 1991
[Personal experience with lovastatin, a HMG-CoA reductase inhibitor (Mevacor, MSD) in the treatment of hypercholesterolemia]H Vaverková, N Skottová, L Pudilová, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Vnitrni Lekarstvi|October 1, 1987
[The importance of collectivism training in medical schools]M Vykydal, V Horcicka, O Weinbergová, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1985
Platelet aggregation in primary hyperlipoproteinemiaH Vaverková, O Weinbergová, M Kubasta, et al.
Vnitrni Lekarstvi|September 1, 1986
[Familial combined hyperlipidemia. I. Variation in the lipoprotein picture]H Vaverková, O Weinbergová, V Horcicka, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1986
Familial combined hyperlipidemia. Part II. Clinical pictureH Vaverková, O Weinbergová, V Horcicka, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1986
Familial combined hyperlipidemia. Part I. Lipid values and the lipoprotein patternH Vaverková, O Weinbergová, V Horcicka, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1982
Biochemical analysis of articular environment in diseases of motor apparatusP Vrublovský, M Vykydal, E Pĕgrímová, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1987
Effect of genetic heterogeneity of hypertriglyceridemia upon the risk of coronary heart diseaseH Vaverková, O Weinbergová, V Horcicka, et al.
Vnitrni Lekarstvi|September 1, 1986
[Familial combined hyperlipidemia. II. Risk of ischemic heart disease]H Vaverková, O Weinbergová, V Horcicka, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1985
Type III hyperlipoproteinaemia: clinicopathological observation of five casesH Vaverková, J Dusek, M Kubasta, et al.
Vnitrni Lekarstvi|May 1, 1991
[Personal experience with lovastatin, a HMG-CoA reductase inhibitor (Mevacor, MSD) in the treatment of hypercholesterolemia]H Vaverková, N Skottová, L Pudilová, et al.
Pageof 3